KANSAS OFFICE of
  REVISOR of STATUTES

  

Home >> Statutes >> Back


Click to open printable format in new window.Printable Format
 | Next

65-4109. Substances included in schedule III. (a) The controlled substances listed in this section are included in schedule III and the number set forth opposite each drug or substance is the DEA controlled substances code which has been assigned to it.

(b) Unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system:

(1)

Any compound, mixture or preparation containing:

(A)

Amobarbital

2126

(B)

Secobarbital

2316

(C)

Pentobarbital
or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule

2271

(2)

Any suppository dosage form containing:

(A)

Amobarbital

2126

(B)

Secobarbital

2316

(C)

Pentobarbital
or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository.

2271

(3)

Any substance which contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, except those substances which are specifically listed in other schedules

2100

(4)

Chlorhexadol

2510

(5)

Lysergic acid

7300

(6)

Lysergic acid amide

7310

(7)

Methyprylon

2575

(8)

Sulfondiethylmethane

2600

(9)

Sulfonethylmethane

2605

(10)

Sulfonmethane

2610

(11)

Tiletamine and zolazepam or any salt thereof
Some trade or other names for a tiletamine-zolazepam combination product: Telazol
Some trade or other names for tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone
Some trade or other names for zolazepam: 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e][1,4]-diazepin-7(1H)-one, flupyrazapon

7295

(12)

Ketamine, its salts, isomers, and salts of isomers

Some other names for ketamine: (±)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone

7285

(13)

Gamma hydroxybutyric acid, any salt, hydroxybutyric compound, derivative or preparation of gamma hydroxybutyric acid contained in a drug product for which an application has been approved under section 505 of the federal food, drug and cosmetic act

(14)

Embutramide

2020

(15)

Perampanel, its salts, isomers, and salts of isomers

Some other names for perampanel: 2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2 dihydropyridin-3-yl) benzonitrile

2261

(c)

Nalorphine

9400

(d) Any material, compound, mixture or preparation containing any of the following narcotic drugs or any salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:

(1)

Not more than 1.8 grams of codeine or any of its salts per 100 milliliters or not more than 90 milligrams per dosage unit with an equal or greater quantity of an isoquinoline alkaloid of opium

9803

(2)

not more than 1.8 grams of codeine or any of its salts per 100 milliliters or not more than 90 milligrams per dosage unit with one or more active, nonnarcotic ingredients in recognized therapeutic amounts

9804

(3)

not more than 1.8 grams of dihydrocodeine or any of its salts per 100 milliliters or not more than 90 milligrams per dosage unit with one or more active, nonnarcotic ingredients in recognized therapeutic amounts

9807

(4)

not more than 300 milligrams of ethylmorphine or any of its salts per 100 milliliters or not more than 15 milligrams per dosage unit with one or more active, nonnarcotic ingredients in recognized therapeutic amounts

9808

(5)

not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit with one or more active, nonnarcotic ingredients in recognized therapeutic amounts

9809

(6)

not more than 50 milligrams of morphine or any of its salts per 100 milliliters or per 100 grams with one or more active, nonnarcotic ingredients in recognized therapeutic amounts

9810

(7)

any material, compound, mixture or preparation containing any of the following narcotic drugs or their salts, as set forth below:

(A)

Buprenorphine

9064

(e) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position or geometric) and salts of such isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:

(1)

Those compounds, mixtures or preparations in dosage unit form containing any stimulant substance listed in schedule II, which compounds, mixtures or preparations were listed on August 25, 1971, as excepted compounds under section 308.32 of title 21 of the code of federal regulations, and any other drug of the quantitive composition shown in that list for those drugs or which is the same, except that it contains a lesser quantity of controlled substances

1405

(2)

Benzphetamine

1228

(3)

Chlorphentermine

1645

(4)

Chlortermine

1647

(5)

Phendimetrazine

1615

(f)

Anabolic steroids

4000

“Anabolic steroid” means any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, and corticosteroids) that promotes muscle growth, and includes:

(1)

3β,17-dihydroxy-5a-androstane

(2)

3α,17β-dihydroxy-5a-androstane

(3)

5a-androstan-3,17-dione

(4)

1-androstenediol (3β,17β-dihydroxy-5α-androst-1-ene)

(5)

1-androstenediol (3α,17β-dihydroxy-5α-androst-1-ene)

(6)

4-androstenediol (3β,17β-dihydroxy-androst-4-ene)

(7)

5-androstenediol (3β,17β-dihydroxy-androst-5-ene)

(8)

1-androstenedione ([5α]-androst-1-en-3,17-dione)

(9)

4-androstenedione (androst-4-en-3,17-dione)

(10)

5-androstenedione (androst-5-en-3,17-dione)

(11)

bolasterone (7α,17α-dimethyl-17β-hydroxyandrost-4-en-3-one)

(12)

boldenone (17β-hydroxyandrost-1,4-diene-3-one)

(13)

boldione (androsta-1,4-diene-3,17-dione)

(14)

calusterone (7β,17α-dimethyl-17β-hydroxyandrost-4-en-3-one)

(15)

clostebol (4-chloro-17β-hydroxyandrost-4-en-3-one)

(16)

dehydrochloromethyltestosterone (4-chloro-17β-hydroxy-17α-methyl-androst-1,4-dien-3-one)

(17)

desoxymethyltestosterone (17α-methyl-5α-androst-2-en-17β-ol) (also known as "madol")

(18)

Δ1-dihydrotestosterone (17β-hydroxy-5α-androst-1-en-3-one) (also known as "1-testosterone")

(19)

4-dihydrotestosterone (17β-hydroxy-androstan-3-one)

(20)

drostanolone (17β-hydroxy-2α-methyl-5α-androstan-3-one)

(21)

ethylestrenol (17α-ethyl-17β-hydroxyestr-4-ene)

(22)

fluoxymesterone (9-fluoro-17α-methyl-11β,17β-dihydroxyandrost-4-en-3-one)

(23)

formebolone (2-formyl-17α-methyl-11α,17β-dihydroxyandrost-1,4-dien-3-one)

(24)

furazabol (17α-methyl-17β-hydroxyandrostano[2,3-c]-furazan)

(25)

13β-ethyl-17β-hydroxygon-4-en-3-one

(26)

4-hydroxytestosterone (4,17β-dihydroxy-androst-4-en-3-one)

(27)

4-hydroxy-19-nortestosterone (4,17β-dihydroxy-estr-4-en-3-one)

(28)

mestanolone (17α-methyl-17β-hydroxy-5-androstan-3-one)

(29)

mesterolone (1α-methyl-17β-hydroxy-[5α]-androstan-3-one)

(30)

methandienone (17α-methyl-17β-hydroxyandrost-1,4-dien-3-one)

(31)

methandriol (17α-methyl-3β,17β-dihydroxyandrost-5-ene)

(32)

methasterone (2α,17α-dimethyl-5α-androstan-17β-ol-3-one)

(33)

methenolone (1-methyl-17β-hydroxy-5α-androst-1-en-3-one)

(34)

17α-methyl-3β,17β-dihydroxy-5a-androstane

(35)

17α-methyl-3α,17β-dihydroxy-5a-androstane

(36)

17α-methyl-3β,17β-dihydroxyandrost-4-ene

(37)

17α-methyl-4-hydroxynandrolone (17α-methyl-4-hydroxy-17β-hydroxyestr-4-en-3-one)

(38)

methyldienolone (17α-methyl-17β-hydroxyestra-4,9(10)-dien-3-one)

(39)

methyltrienolone (17α-methyl-17β-hydroxyestra-4,9,11-trien-3-one)

(40)

methyltestosterone (17α-methyl-17β-hydroxyandrost-4-en-3-one)

(41)

mibolerone (7α,17α-dimethyl-17β-hydroxyestr-4-en-3-one)

(42)

17α-methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α-methyl-5α-androst-1-en-3-one) (also known as "17-α-methyl-1-testosterone")

(43)

nandrolone (17β-hydroxyestr-4-en-3-one)

(44)

19-nor-4-androstenediol (3β, 17β-dihydroxyestr-4-ene)

(45)

19-nor-4-androstenediol (3α, 17β-dihydroxyestr-4-ene)

(46)

19-nor-5-androstenediol (3β, 17β-dihydroxyestr-5-ene)

(47)

19-nor-5-androstenediol (3α, 17β-dihydroxyestr-5-ene)

(48)

19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione)

(49)

19-nor-4-androstenedione (estr-4-en-3,17-dione)

(50)

19-nor-5-androstenedione (estr-5-en-3,17-dione)

(51)

norbolethone (13β, 17α-diethyl-17β-hydroxygon-4-en-3-one)

(52)

norclostebol (4-chloro-17β-hydroxyestr-4-en-3-one)

(53)

norethandrolone (17α-ethyl-17β-hydroxyestr-4-en-3-one)

(54)

normethandrolone (17α-methyl-17β-hydroxyestr-4-en-3-one)

(55)

oxandrolone (17α-methyl-17β-hydroxy-2-oxa-[5α]-androstan-3-one)

(56)

oxymesterone (17α-methyl-4,17β-dihydroxyandrost-4-en-3-one)

(57)

oxymetholone (17α-methyl-2-hydroxymethylene-17β-hydroxy-[5α]-androstan-3-one)

(58)

prostanozol (17β-hydroxy-5α-androstano[3,2-c]pyrazole)

(59)

stanozolol (17α-methyl-17β-hydroxy-[5α]-androst-2-eno[3,2-c]-pyrazole)

(60)

stenbolone (17β-hydroxy-2-methyl-[5α]-androst-1-en-3-one)

(61)

testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone)

(62)

testosterone (17β-hydroxyandrost-4-en-3-one)

(63)

tetrahydrogestrinone (13β, 17α-diethyl-17β-hydroxygon-4,9,11-trien-3-one)

(64)

trenbolone (17β-hydroxyestr-4,9,11-trien-3-one)

(65)

any salt, ester, or isomer of a drug or substance described or listed in this paragraph, if that salt, ester, or isomer promotes muscle growth.

(A)

Except as provided in (B), such term does not include an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the United States' secretary of health and human services for such administration.

(B)

If any person prescribes, dispenses or distributes such steroid for human use, such person shall be considered to have prescribed, dispensed or distributed an anabolic steroid within the meaning of this subsection (f).

(g) Any material, compound, mixture or preparation which contains any quantity of the following hallucinogenic substance, its salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:

(1)

Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States food and drug administration approved product

7369

Some other names for dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro -6-6-9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-0l, or (-)-delta-9-(trans)-tetrahydrocannabinol.

(h) The board may except by rule any compound, mixture or preparation containing any stimulant or depressant substance listed in subsection (b) from the application of all or any part of this act if the compound, mixture or preparation contains one or more active medicinal ingredients not having a stimulant or depressant effect on the central nervous system and if the admixtures are included therein in combinations, quantity, proportion or concentration that vitiate the potential for abuse of the substances which have a stimulant or depressant effect on the central nervous system.

History: L. 1972, ch. 234, § 9; L. 1974, ch. 258, § 4; L. 1978, ch. 257, § 2; L. 1982, ch. 269, § 4; L. 1985, ch. 220, § 3; L. 1989, ch. 200, § 3; L. 1991, ch. 199, § 3; L. 1992, ch. 174, § 3; L. 2000, ch. 108, § 3; L. 2001, ch. 171, § 4; L. 2011, ch. 83, § 5; L. 2014, ch. 79, § 2; L. 2015, ch. 27, § 3; L. 2016, ch. 95, § 3; L. 2018, ch. 101, § 3; May 24.

Revisor's Note:

Section was also amended by L. 2011, ch. 10, § 3, but that version was repealed by L. 2011, ch. 83, § 9.

Section was not amended in the 2016 session.


 | Next

2020 SPECIAL SESSION
Information for Special Session 2020

LEGISLATIVE COORDINATING COUNCIL
3/24/2020 Meeting Notice Agenda
3/27/2020 Meeting Notice Agenda
3/29/2020 Meeting Notice Agenda
4/2/2020 Meeting Notice Agenda
4/8/2020 Meeting Notice Agenda
4/13/2020 Meeting Notice - Cancelled
4/22/2020 Meeting Notice Agenda
5/6/2020 Meeting Notice Agenda
3/29/2020 Covid-19 Map
LCC Policies

REVISOR OF STATUTES
2019
2020
Chapter 72 Statute Transfer List
Kansas School Equity & Enhancement Act
Gannon v. State
General Information, Legal Analysis & Research
2018 Amended & Repealed Statutes
2017 Amended & Repealed Statutes
2016 Amended & Repealed Statutes
2015 Amended & Repealed Statutes
2014 Amended & Repealed Statutes
2013 Amended & Repealed Statutes

USEFUL LINKS
Session Laws

 OTHER LEGISLATIVE SITES
Kansas Legislature
Administrative Services
Division of Post Audit
Research Department